Casma Therapeutics adds Dr. Millie Ray to its Board along with raising $50m Series B financing led by The Column Group

– USA, MA –  Casma Therapeutics, Inc., a biotechnology company harnessing autophagy and the lysosome to design powerful new medicines, today announced the completion of a $50 million Series B financing led by The Column Group, alongside existing investor Third Rock Ventures, and new investors, Eventide Asset Management, LLC and Schroder Adveq, as well as other undisclosed institutional investors.…

Circle Pharma adds Peter Svennilson, Dr Thilo Schroeder and Dr John Josey (chairman) to its Board along with raising $45m Series B financing led by The Column Group

– USA, CA –  Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced that it has raised $45 million in a Series B financing led by The Column Group, with participation by Nextech Invest, with all investors from the prior round – ShangPharma, LifeForce Capital, and the Berkeley Catalyst Fund – joining the financing.…